12 Stocks Moving In Tuesday's Pre-Market Session

Gainers

Altisource Portfolio Solutions S.A. ASPS rose 9.18 percent to $32.22 in pre-market trading after dropping 5.69 percent on Monday.

Ecolab Inc. ECL rose 5.87 percent to $120.98 in pre-market trading. Ecolab is expected to report quarterly earnings today.

Mylan NV MYL shares rose 3.84 percent to $44.35 in pre-market trading after the company reported upbeat Q1 earnings and named Kenneth Parks as CFO.

Pfizer Inc. PFE shares rose 2.87 percent to $33.74 in pre-market trading as the company reported stronger-than-expected results for its first quarter and raised its forecast for the full year.

Starwood Hotels & Resorts Worldwide Inc HOT shares rose 1.35 percent to $83.23 in pre-market trading as the company reported better-than-expected quarterly earnings.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Losers

Revolution Lighting Technologies Inc RVLT shares fell 16.79 percent to $5.75 in pre-market trading as the company priced 2.775 million share offering at $5.25 per share.

Community Health Systems CYH shares fell 13.28 percent to $13.65 in pre-market trading as the company reported weaker-than-expected results for its first quarter on Monday.

INC Research Holdings Inc INCR fell 4.95 percent to $45.10 in pre-market trading. INC Research reported an 8 million share secondary offering.

PRA Health Sciences Inc PRAH shares fell 4.91 percent to $46.50 in pre-market trading as the company reported an offering of 5 million shares of common stock.

Amplify Snack Brands Inc BETR shares fell 4.41 percent to $14.74 in pre-market trading. Amplify Snack Brands reported Q1 adjusted earnings of $0.13 per share on sales of $54.3 million.

Commscope Holding Company Inc COMM shares fell 4.09 percent to $29.10 in pre-market trading as the company reported the sale of 20 million shares by an affiliate of The Carlyle Group.

Sarepta Therapeutics Inc SRPT shares fell 4.02 percent to $17.20 in pre-market trading after rising 26.29 percent on Monday. Leerink Swann downgraded Sarepta Therapeutics from Market Perform to Underperform and lowered the price target from $13.00 to $5.00.

Posted In: NewsMovers & ShakersPre-Market OutlookMarketsMovers#PreMarket Gainers#PreMarket LosersTop Gainers
We simplify the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...